Article Information
History
- December 2, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Feng Fan1,
- Xin Zhang1,
- Zhiyu Zhang1,
- Yuan Ding1,
- Limei Wang1,
- Xin Xu1,
- Yaying Pan2,
- Fang-Yuan Gong2,
- Lin Jiang3,
- Lingyu Kang3,
- Zhihua Kou1,
- Gan Zhao1,
- Bin Wang1,* and
- Xiao-Ming Gao1,*
- 1Advaccine Biopharmaceutics (Suzhou) Co. Ltd, Suzhou, China
- 2School of Biological Science and Basic Medicine, Soochow University, Suzhou, China
- 3Shenzhen Qinglan Biotechnology Co. Ltd., Shenzhen, China
- ↵*Correspondence: Xiao-Ming Gao (gaoxiaoming{at}advaccine.com) or Bin Wang (bwang{at}advaccine.com)